Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Surgical Research

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JSS.2006.02.011PMID 16650873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.

  2006cited by this paper
• Novel peptides secreted from human neuroblastoma: useful clinical tools?

  2006cited by this paper
• Proteomic Analysis of Cellular Response to Osmotic Stress in Thick Ascending Limb of Henle’s Loop (TALH) Cells*

  2005cited by this paper
• A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death.

  2005cited by this paper
• Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies.

  2005cited by this paper
• Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: The lack of effect of ERK in p53 mediated copper induced apoptosis

  2005cited by this paper
• Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines

  2005cited by this paper
• Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH‐SY5Y human neuroblastoma cells

  2004cited by this paper
• Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells.

  2004cited by this paper
• Targeting the mitogen-activated protein kinase cascade to treat cancer

  2004cited by this paper
• Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.

  2004cited by this paper
• Proteomic analysis of hyperoxia‐induced responses in the human choriocarcinoma cell line JEG‐3

  2004cited by this paper
• Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death*

  2004cited by this paper
• A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells.

  2004cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003cited by this paper
• The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species

  2003cited by this paper
• GRP94/gp96 Elicits ERK Activation in Murine Macrophages

  2003cited by this paper
• The Initiation Factor eIF4A Is Involved in the Response to Lithium Stress in Saccharomyces cerevisiae *

  2002cited by this paper
• Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes

  2002cited by this paper
• DNA (cytosine) methyltransferase overexpression is associated with acquired drug resistance of murine neuroblastoma cells.

  2001cited by this paper
• Activator protein 1 activation following hypoosmotic stress in HepG2 cells is actin cytoskeleton dependent.

  2001cited by this paper
• Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.

  2000cited by this paper
• N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.

  2000cited by this paper
• Identification of genes differentially expressed in association with acquired cisplatin resistance

  2000cited by this paper
• p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma.

  2000cited by this paper
• Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes.

  1999cited by this paper
• Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells

  1999cited by this paper
• Cellular response to cancer chemopreventive agents: contribution of the antioxidant responsive element to the adaptive response to oxidative and chemical stress.

  1999cited by this paper
• Glucose‐regulated stresses induce resistance to camptothecin in human cancer cells

  1996cited by this paper
• Cold shock stress-induced proteins in Bacillus subtilis

  1996cited by this paper
• Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II.

  1995cited by this paper
• The induction of pyruvate kinase synthesis by heat shock in Xenopus laevis embryos.

  1993cited by this paper
• Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.

  1989cited by this paper
• Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells.

  1987cited by this paper
• Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.

  1978cited by this paper

• Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells

  2015cites this paper
• Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome

  2012cites this paper
• Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth

  2012cites this paper
• Application of Proteomics to Soft Tissue Sarcomas

  2012cites this paper
• Estudio del valor patogénico de la expresión y ruta de señalización de KIT e IGF1R en Sarcoma de Ewing: ¿nuevas posibles dianas terapeúticas?

  2011cites this paper
• Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model

  2010cites this paper
• Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress

  2010cites this paper
• Proteomic approaches in neuroblastoma: a complementary clinical platform for the future

  2009cites this paper
• Alterations in Barrett's‐related adenocarcinomas: A proteomic approach

  2008cites this paper
• Molecular Mechanisms of Protein Kinase A Signaling Pathway on Estrogen Receptor Action in Breast Cancer

  2006cites this paper
• Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.

  2006cites this paper